Envoy Medical (COCH) announces that the European Patent Office has granted the Company Patent No. 3858425, titled,” Implantable Modular Cochlear Implant System with Communication System and Network.” The patent relates to a modular cochlear implant system configured to receive input signals from an implantable source and a wireless receiving device and output a stimulation signal based on the received input signals and a programmable mixing ratio representative of the relative contributions of the input signals to the stimulation signal.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COCH:
- Envoy Medical receives FDA approval to initiate study for hearing device
- Envoy Medical supports ITEM Coalition letter to CMS on hearing devices
- Envoy Medical announces AMA CPT Editorial Panel approved codes for AMEI
- Envoy Medical initiated with a Buy at Brookline
- Envoy Medical celebrates one year trading as public company